UPDATE: BMO Capital Starts Phathom Pharmaceuticals (PHAT) at Outperform
Tweet Send to a Friend
(Updated - February 17, 2021 5:02 AM EST)
BMO Capital analyst Gary Nachman initiates coverage on Phathom Pharmaceuticals (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BMO Capital analyst Gary Nachman initiates coverage on Phathom Pharmaceuticals (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
